Serving 500+ biopharmaceutical companies globally:
Globalization has disrupted many industries, initially shifting unskilled labor employment from high wage-cost industrialized nations to lower wage-cost emerging economies. There has been a trend toward moving increasingly skilled work away from industrialized nations, which raises the question−has innovative research and development been affected by globalization and why is the relocation of innovation much more than a simple economic concern?
In this new paper from DrugPatentWatch publisher Yali Friedman, in ACS Medicinal Chemistry Letters, data from DrugPatentWatch.com is used to investigate shifts in the countries where drugs are invented. Also discussed are the implications of growth in innovation output from emerging economies.
You can read this recent paper at pubs.acs.org/doi/pdf/10.1021/acsmedchemlett.7b00185 and you can read more about Dr. Friedman's rankings of global biotechnology innovation at www.thinkbiotech.com/globalbiotech/